• Study on Imaging with 89Zr-Atezolizumab to Monitor Immune Responses in Patients with Metastatic Triple Negative Breast Cancer Using Atezolizumab and Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden

  • Study Comparing Rituximab and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Safety and Effects of NGI226 Microparticles for Patients with Achilles Tendinopathy

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany The Netherlands

  • Study on the Effect of a New Moisturiser with Paraffin and Liquid Paraffin on Preventing Eczema Relapse in Children

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Sweden

  • Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Bulgaria Denmark Germany Greece Hungary +5

  • Study on Upadacitinib for Adults with Active Axial Spondyloarthritis

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Czechia France Germany Hungary +3

  • Study on ENX-101 for Treating Focal Epilepsy in Patients Using 1 to 4 Antiseizure Medications

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany The Netherlands Spain

  • Study on Trehalose Dihydrate for Treating Spinocerebellar Ataxia in Adults

    Not recruiting

    4 1
    Investigated Diseases:
    Investigated Drugs:
    Germany Portugal Spain

  • Study Comparing [177Lu]LU-PSMA-I&T and Hormone Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Spain

  • Study on the Safety and Effectiveness of 19CP02 for Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

    Not recruiting

    2 1 1
    Investigated Drugs:
    Belgium Finland The Netherlands

powered by